Insight
Thailand in focus - What's new in Non-Life August 2022
The latest on Thailand non-life insurance: Premiums rise 2.3% 1Q versus the same period in 2021, while net loss ratio increases to 156.4%, up from 57.3%.
When evaluating multiyear payment arrangements, it's important to assess retention rates for patients with rare diseases. This study found subscriber retention is high for adults diagnosed with a rare disease and excluding this assessment could lead to inaccurate expectations for health insurers and plan administrators.
This article was originally published by JMCP.
Insight
The latest on Thailand non-life insurance: Premiums rise 2.3% 1Q versus the same period in 2021, while net loss ratio increases to 156.4%, up from 57.3%.
We’re here to help you break through complex challenges and achieve next-level success.
An analysis of member retention patterns for adult rare disease cohorts to support evaluating multiyear payment arrangements for novel therapies
Evaluating multiyear payment arrangements? Assess retention rates for patients with rare diseases.